| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/22/1992 | CN1017527B Process for preparing optically active oxo-isoindolinyl derivatives |
| 07/21/1992 | US5132413 Sugar chain |
| 07/21/1992 | US5132328 Lipoxygenase inhibitors as antiinflammatory agents or antiallergens |
| 07/21/1992 | US5132304 Benzothiazine derivatives and their applications as medicinal products or as synthesis intermediates for medicinal products |
| 07/21/1992 | US5132300 Beta-lactam elastase inhibitors |
| 07/21/1992 | CA1305478C Naphthyridine and pyridopyrazine compounds and pharmaceutical usage thereof |
| 07/21/1992 | CA1305423C Pharmaceutical preparations for topical application, processes for theirmanufacture, and their use |
| 07/18/1992 | CA2058651A1 Sulphonamide derivatives |
| 07/17/1992 | CA2059353A1 Diazepines substituted in the 6-position, processes for their preparation and their preparation and their use as pharmaceutical compositions |
| 07/16/1992 | CA2058254A1 Benzodioxole derivatives |
| 07/15/1992 | EP0494621A1 Substituted alkenoic acid and its derivatives |
| 07/15/1992 | EP0494265A1 Rheumatoid factor activity encoded by variant immunoglobulin variable region |
| 07/15/1992 | EP0494256A1 Evaluative means for detecting inflammatory reactivity and for predicting response to stress |
| 07/15/1992 | CN1017425B Process for the preparation of heterocyclic amide derivatives |
| 07/14/1992 | US5130487 Aminopropanol derivatives, process for their preparation and pharmaceutical compositions comprising the same |
| 07/14/1992 | US5130485 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
| 07/14/1992 | US5130335 Tetralin esters of phenols or benzoic acids having retinoid like activity |
| 07/14/1992 | US5130323 Anticoagulants, thromboxane A2 antagonist and enzyme inhibitor for treatment of nephtitis and asthma |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | CA1305166C 1-hydroxy-3-(n-methyl-n-proplylamino)propane-1,1- diphosphonic acid, pharmaceutical compositions and methods of use |
| 07/14/1992 | CA1305151C Antiallergy and antiinflammatory agents |
| 07/14/1992 | CA1305150C Derivatives of spiro (4,5) decane, process for their preparation and pharmaceutical compositions containing the same |
| 07/14/1992 | CA1305147C Benzo¬5,6|cycloheptapyridines, compositions and methods of use |
| 07/14/1992 | CA1305058C Parenteral suspension containing diclofenac |
| 07/11/1992 | WO1992012151A1 N-alkyl quinuclidinium salts as substance p antagonists |
| 07/11/1992 | CA2100163A1 N-alkyl quinuclidinium salts |
| 07/11/1992 | CA2058884A1 Substituted alkenoic acid and its derivatives |
| 07/10/1992 | WO1992012141A1 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011359A1 A truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/09/1992 | WO1992011032A1 Radionuclide labelled particles useful for radiation synovectomy |
| 07/09/1992 | WO1992011010A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098917A1 New 3,4-dihydroisoquinoline derivatives and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098848A1 Truncated interleukin-1 receptor gene for the treatment of arthritis |
| 07/09/1992 | CA2097927A1 Radionuclide labelled particles useful for radiation synovectomy |
| 07/08/1992 | WO1992012161A1 Novel pyrimido-benzothiazines |
| 07/08/1992 | EP0494047A1 Use of carbazones for the treatment of rheumatoid diseases |
| 07/08/1992 | EP0493496A1 Ibuprofen triturates and topical compositions containing same |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0493404A1 Topical antiinflammatory compositions with minimal systemic absorption |
| 07/08/1992 | CA2099558A1 Pyrimido-benzothiazines |
| 07/07/1992 | US5128479 Oxidized diphenylheteroalkanes |
| 07/07/1992 | US5128373 Storage stability |
| 07/07/1992 | US5128352 Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides |
| 07/07/1992 | US5128334 Analgesic and anti-inflammatory medicine |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/07/1992 | CA1304687C Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage |
| 07/01/1992 | EP0493031A1 Dihydrobenzofuran carboxamides and process for their preparation |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0362270B1 Steroid lotion |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 06/30/1992 | US5126371 Diarylacetylenes, their preparation and their use |
| 06/30/1992 | US5126365 Bicyclic derivatives |
| 06/30/1992 | US5126357 Anti-inflammatory picolyselenobenzamides and salts thereof |
| 06/30/1992 | US5126356 Antiischemic agents |
| 06/30/1992 | US5126354 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives |
| 06/30/1992 | US5126341 Anti-inflammatory 1,8-naphthyridin-2-one derivatives |
| 06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
| 06/30/1992 | CA1304391C Lipoxygenase inhibiting compounds |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | WO1992010477A1 Medicaments |
| 06/25/1992 | WO1992010164A1 Agent for reducing the growth of, or removing, human body hair |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/25/1992 | DE4041482A1 Neue pharmazeutische verwendung carbocyclisch und heterocyclisch annelierter dihydropyridine New pharmaceutical use carbocyclic and heterocyclic fused-dihydropyridines |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/24/1992 | EP0490919A1 Cytoprotective fatty moiety compounds |
| 06/24/1992 | CN1062140A Process for preparing benzoxazin-and thiazin compounds |
| 06/23/1992 | US5124455 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| 06/23/1992 | US5124350 Leukotriene b4 antagonists |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | CA1304091C 2,6-bis(chloromethyloxy-carbonyloxymethyl)-pyridine and a process for preparing same |
| 06/23/1992 | CA1303994C2 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds |
| 06/22/1992 | CA2058168A1 New use of peptide derivative |
| 06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
| 06/17/1992 | EP0490689A1 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1) |
| 06/17/1992 | EP0490648A1 Pharmaceutical agents |
| 06/17/1992 | EP0489779A1 Ophthalmic composition |
| 06/17/1992 | EP0489778A1 Anti-inflammatory active ingredients for cosmetic preparations |
| 06/16/1992 | US5122534 Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| 06/16/1992 | CA1303607C 6.alpha.-METHYLCORTICOIDS AND THEIR MANUFACTURE AND USE |
| 06/16/1992 | CA1303508C Use of dihydro benzopyran derivatives |
| 06/16/1992 | CA1303507C Anti-inflammatory compositions |
| 06/14/1992 | WO1992010190A1 Novel csaids |
| 06/14/1992 | CA2098177A1 Csaids |
| 06/13/1992 | WO1992010469A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/13/1992 | CA2094247A1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 06/12/1992 | WO1992010464A1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
| 06/12/1992 | CA2098112A1 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities |
| 06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
| 06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
| 06/11/1992 | WO1992009567A1 Anti-inflammatory compounds |
| 06/11/1992 | WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | WO1992009282A1 Treatment for tissue ulceration |
| 06/11/1992 | WO1992009268A1 Prevention of synovial adhesions |
| 06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
| 06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |